CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells

Daniella Herszfeld; Ernst Jurgen Wolvetang; Emma Langton-Bunker; Tung-Liang Chung; Adam A Filipczyk; Souheir Houssami; Pegah Jamshidi; Karen Lan Lan Koh; Andrew Lacy Laslett; Anna Emilia Michalska; Linh Thuy Vu Nguyen; B Reubinoff; Irene Tellis; Jonathan M Auerbach; Carol J Ording; Leendert H Looijenga; Martin Frederick Pera

doi:10.1038/nbt1197

CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells

Daniella Herszfeld
, Ernst Jurgen Wolvetang
, Emma Langton-Bunker
, Tung-Liang Chung
, Adam A Filipczyk
, Souheir Houssami
, Pegah Jamshidi
, Karen Lan Lan Koh
, Andrew Lacy Laslett
, Anna Emilia Michalska
, Linh Thuy Vu Nguyen
, B Reubinoff
, Irene Tellis
, Jonathan M Auerbach
, Carol J Ording
, Leendert H Looijenga
, Martin Frederick Pera

Hudson Institute - Department of Molecular and Translational Science

Research output: Contribution to journal › Article › Research › peer-review

145 Citations (Scopus)

Original language	English
Pages (from-to)	351 - 357
Number of pages	6
Journal	Nature Biotechnology
Volume	24
DOIs	https://doi.org/10.1038/nbt1197
Publication status	Published - 2006

Access to Document

10.1038/nbt1197

Cite this

Herszfeld, D., Wolvetang, E. J., Langton-Bunker, E., Chung, T.-L., Filipczyk, A. A., Houssami, S., Jamshidi, P., Koh, K. L. L., Laslett, A. L., Michalska, A. E., Nguyen, L. T. V., Reubinoff, B., Tellis, I., Auerbach, J. M., Ording, C. J., Looijenga, L. H., & Pera, M. F. (2006). CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nature Biotechnology, 24, 351 - 357. https://doi.org/10.1038/nbt1197

@article{d53dbd0aaa2d4c28850d20f3b2aebf9e,

title = "CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells",

author = "Daniella Herszfeld and Wolvetang, \{Ernst Jurgen\} and Emma Langton-Bunker and Tung-Liang Chung and Filipczyk, \{Adam A\} and Souheir Houssami and Pegah Jamshidi and Koh, \{Karen Lan Lan\} and Laslett, \{Andrew Lacy\} and Michalska, \{Anna Emilia\} and Nguyen, \{Linh Thuy Vu\} and B Reubinoff and Irene Tellis and Auerbach, \{Jonathan M\} and Ording, \{Carol J\} and Looijenga, \{Leendert H\} and Pera, \{Martin Frederick\}",

year = "2006",

doi = "10.1038/nbt1197",

language = "English",

volume = "24",

pages = "351 -- 357",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

}

Herszfeld, D, Wolvetang, EJ, Langton-Bunker, E, Chung, T-L, Filipczyk, AA, Houssami, S, Jamshidi, P, Koh, KLL, Laslett, AL, Michalska, AE, Nguyen, LTV, Reubinoff, B, Tellis, I, Auerbach, JM, Ording, CJ, Looijenga, LH & Pera, MF 2006, 'CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells', Nature Biotechnology, vol. 24, pp. 351 - 357. https://doi.org/10.1038/nbt1197

TY - JOUR

T1 - CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells

AU - Herszfeld, Daniella

AU - Wolvetang, Ernst Jurgen

AU - Langton-Bunker, Emma

AU - Chung, Tung-Liang

AU - Filipczyk, Adam A

AU - Houssami, Souheir

AU - Jamshidi, Pegah

AU - Koh, Karen Lan Lan

AU - Laslett, Andrew Lacy

AU - Michalska, Anna Emilia

AU - Nguyen, Linh Thuy Vu

AU - Reubinoff, B

AU - Tellis, Irene

AU - Auerbach, Jonathan M

AU - Ording, Carol J

AU - Looijenga, Leendert H

AU - Pera, Martin Frederick

PY - 2006

Y1 - 2006

U2 - 10.1038/nbt1197

DO - 10.1038/nbt1197

M3 - Article

SN - 1087-0156

VL - 24

SP - 351

EP - 357

JO - Nature Biotechnology

JF - Nature Biotechnology

ER -